Home/Photys Therapeutics/Alexandra Joseph, PhD
AJ

Alexandra Joseph, PhD

Chief Scientific Officer

Photys Therapeutics

Photys Therapeutics Pipeline

DrugIndicationPhase
p53-Y220C-BET Bifunctionalp53-Y220C-mutant cancersPreclinical
IRAK4 DegraderOncology/Immunology (licensed to Polymed)Phase 1-ready